The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.
We have made huge strides in research and treatment for children with cancer, improving their chances of survival. With your support today, we can discover kinder treatments and offer more children the hope of a cure.
Tommy Edwards was just four years old when his parents noticed symptoms suggesting something wasn’t right. Tests revealed he had acute lymphoblastic leukaemia (ALL). Following nearly three years of treatment, Tommy is now looking towards the future. His father, Chris, explains how groundbreaking work by scientists at the ICR is giving them hope for the future.
The Institute of Cancer Research, London, strongly welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the US Food and Drug Administration (FDA) for treating the most common type of advanced breast cancer.
The Queen’s Anniversary Prize recognises the transformational breast cancer research programme, which has not only improved outcomes for patients in the UK but also benefitted global healthcare systems and economies.
Our competitive PhD programme is designed for the next generation of world-leading cancer researchers who will benefit from exceptional research facilities.
We aim to attract the best scientific minds who will be working at the forefront of cancer research, in an environment that’s collaborative, international and inclusive.
We draw upon our excellent scientists and facilities to further our world-class cancer research. We work with funders to deliver major research centres and collaborations.
Our research is made possible by our generous community of donors and supporters. Help transform the lives of people with cancer.
We are internationally renowned for driving scientific discoveries on cancer and came second of all UK universities in analysis of the 2021 Research Excellence Framework.
The ICR conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.
We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.
The ICR-CTSU leads high-quality international cancer clinical trials, and their findings directly influence clinical practice within the NHS and worldwide.
The ICR and Imperial College London are working together to open up new frontiers in cancer research.
Search is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians.
Our state-of-the-art drug discovery centre will enable us to create more and and better cancer drugs
“I survived cancer as a child and now I’m working to defeat it” – Andrew’s story
Using the principles of evolution to defeat cancer